2022 Multidisciplinary Spine Oncology Symposium - On Demand

The Memorial Sloan Kettering Cancer Center 2022 Multidisciplinary Spine Oncology Symposium is focused on helping providers create multidisciplinary spine-tumor programs at their own institutions.

Spine tumor management has evolved dramatically over the past decade with the development of advanced radiation, surgical, and interventional techniques. The NOMS framework will be used as a foundation to provide attendees with the tools to integrate new technologies and evidence-based medicine that will lead to optimal care for your patients in a quickly changing oncology landscape.

This multidisciplinary series of lectures provides information about the diagnosis and treatment of patients with spinal tumors. Surgical, interventional, radiation, and pharmacological treatment options will be discussed.

Who Should Attend

This on demand program is designed for physicians, physician extenders, and nurses in practice and training, in the fields of internal medicine, family practice, neurology, medical and radiation oncology, interventional and diagnostic radiology, pain management, physiatry, neurosurgery and orthopedic surgery who are interested in advancing their understanding of primary and metastatic spinal tumors.

On Demand Content

This on demand course consists of lectures, case studies, and recorded Q&A with faculty, plus PDFs of speaker PowerPoint presentations. Select the 'Register' tab at the top of this page to purchase this program. Once you have successfully registered, access to the course materials will be available under the 'Course Content' tab.

1. Describe the NOMS decision framework as the cornerstone of multidisciplinary care for spine tumors.
2. Recognize the ever expanding role of Spine Stereotactic Body Radiotherapy in the treatment of metastatic and primary spine tumors
3. Explore the evolution toward minimally invasive techniques in the treatment of spine metastases.
4. Assess when percutaneous cement augmentation is not enough in the treatment of pathologic fractures.
5. Discuss the complexities of spine-tumor rehabilitation.
6. Examine new techniques in oncologic pain management.
7. Define unique rehabilitation needs in the cancer patient.
8. Review integrated therapy in Neurofibromatosis.

On Demand Access Fees

• Physicians (MDs, PhDs and DOs): $150
• Residents, Fellows, Nurses, Techs and Other Healthcare Providers: $100
• Industry Professionals: $275 

Discounts/Promotions

• A registration discount is available for MSK Alumni, and MSK Cancer Alliance to attend a MSK CME course. If you are a member of one of these groups, contact [email protected] for details.
• Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify [email protected].

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Registration fees for this online CME activity are non-refundable 

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Recorded/Review Date: April 22, 2022; Original Release Date: June 7, 2022; Termination Date: March 7, 2023

MSK Course Directors 

Mark Bilsky, MD
Attending Neurosurgeon
Chief, Multi-Disciplinary Spine Tumor Service

Yoshiya (Josh) Yamada, MD
Attending Radiation Oncologist

Invited Course Faculty 

Kristin Janson Redmond, MD, MPH
Department of Radiation Oncology
Johns Hopkins
Baltimore, MD

John Shin, MD
Department of Neurosurgery
Massachusetts General Hospital
Boston, MA

MSK Course Faculty

Ori Barzilai, MD
Department of Neurosurgery

Victoria Brennan, MBBch, BAO
Department of Radiation Oncology

Aimee Crago, MD, PhD
Department of Surgery

Amitabh Gulati, MD
Department of Anesthesia Pain

Daniel S. Higginson, MD
Department of Radiation Oncology

Eric Lis, MD
Department of Interventional Radiology

Boris A. Mueller, MD, MPH
Department of Radiation Oncology

W. Christopher Newman, MD
Department of Neurosurgery

Anna F. Piotrowski, MD
Department of Neurology

Lisa Marie Ruppert, MD
Department of Rehab/Neurology

Adam Schmitt, MD
Department of Radiation Oncology

Max Vaynrub, MD
Department of Surgery

Divya Yerramilli, MD, MBE
Department of Radiation Oncology

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.